Share Price and Basic Stock Data
Last Updated: January 9, 2026, 4:21 am
| PEG Ratio | 1.83 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vera Synthetic Ltd operates in a sector that has not been explicitly identified, yet its financial performance reveals a significant trajectory in revenue growth. The company reported sales of ₹40.70 Cr in FY 2023, which represented a substantial increase from ₹34.98 Cr in FY 2022. Notably, the company’s quarterly revenue reached ₹40.71 Cr in Mar 2023, indicating a robust operational capability. However, in the subsequent quarters, sales experienced fluctuations, recording ₹21.55 Cr in Sep 2023 and a slight increase to ₹21.56 Cr in Mar 2024. This trend highlights the company’s capability to scale operations but also suggests volatility in demand. Over the years, from Mar 2014’s ₹19.58 Cr to the latest ₹45.19 Cr TTM, the revenue growth trajectory reflects a compounded annual growth rate (CAGR) that underscores its potential in the market. Despite these achievements, the company’s operating profit margin (OPM) stood at a modest 10.97%, indicating room for improvement in cost management and pricing strategies.
Profitability and Efficiency Metrics
Vera Synthetic Ltd’s profitability metrics exhibit both strengths and weaknesses. The company recorded a net profit of ₹2.75 Cr in the most recent fiscal year, a marginal increase from ₹2.03 Cr in FY 2025. The earnings per share (EPS) for FY 2025 stood at ₹4.11, reflecting a positive growth trajectory from ₹3.69 in FY 2023. However, the operating profit margin (OPM) has shown variability, declining to 1.58% in Sep 2023 from 7.20% in Mar 2023, which raises concerns about operational efficiency. The interest coverage ratio (ICR) was exceptionally high at 6735.87x, indicating that the company is not reliant on debt for financing operations, which is a significant strength. However, the cash conversion cycle (CCC) of 96.32 days suggests inefficiencies in managing working capital, particularly in debtor and inventory management. The reported return on equity (ROE) of 9.07% and return on capital employed (ROCE) of 12.3% align with industry norms, suggesting a balanced approach to generating shareholder value.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vera Synthetic Ltd exhibits a commendable level of financial health, characterized by a market capitalization of ₹34.5 Cr and minimal borrowing of only ₹0.03 Cr. The total reserves have increased significantly to ₹20.00 Cr, demonstrating the company’s capability to retain earnings for future growth. The company’s current ratio stands at 5.44x, indicating a strong liquidity position, while the quick ratio is at 3.72x, reflecting the firm’s ability to meet short-term obligations without relying on inventory sales. The price-to-book value (P/BV) ratio of 1.42x suggests that the market values the company slightly above its book value, which is a positive indicator for investors. The low long-term debt to equity ratio of 0.00 indicates a conservative approach to leveraging, minimizing financial risk. However, the asset turnover ratio of 1.68% suggests that there might be inefficiencies in utilizing assets to generate revenue, which is an area for potential improvement.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vera Synthetic Ltd reveals a strong promoter holding of 68.66%, reflecting significant insider confidence in the company’s future prospects. The public holding stands at 31.34%, which indicates a balanced distribution of shares among retail investors. The total number of shareholders has increased to 115, suggesting a growing interest in the company. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) could be a concern, as their participation often signals confidence from larger institutional players. The gradual increase in promoter shareholding from 59.86% in Mar 2020 to 68.66% in Sep 2023 indicates a strategic move to consolidate control and potentially enhance shareholder value. This trend might instill confidence among existing shareholders while attracting new investors, particularly if the company can demonstrate sustainable growth and improved profitability metrics.
Outlook, Risks, and Final Insight
Looking ahead, Vera Synthetic Ltd presents both opportunities and risks. The company’s strong liquidity position and high interest coverage ratio provide a solid foundation for future growth. However, the volatility in revenue and declining operating margins raise concerns about operational efficiency. The absence of institutional investors could limit the stock’s appeal for larger investors, impacting liquidity. Additionally, the company must address its cash conversion cycle to enhance working capital management. Potential growth drivers include further operational efficiencies, expansion into new markets, or product lines that could bolster revenue. Conversely, risks such as fluctuating demand and operational challenges could impede growth if not managed effectively. Overall, with a focus on improving profitability and operational efficiency, Vera Synthetic Ltd has the potential to enhance shareholder value significantly in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 89.9 Cr. | 23.4 | 784/22.8 | 0.88 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,686 Cr. | 167 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 43.8 Cr. | 3.43 | 8.19/3.30 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,355.82 Cr | 209.12 | 325.03 | 219.28 | 0.26% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.01 | 15.56 | 14.70 | 13.43 | 17.40 | 17.58 | 19.61 | 40.71 | 21.55 | 21.56 | 23.39 | 19.11 | 26.08 |
| Expenses | 16.37 | 13.97 | 12.42 | 13.36 | 16.57 | 15.35 | 17.93 | 37.78 | 21.21 | 20.26 | 21.23 | 17.52 | 23.22 |
| Operating Profit | 1.64 | 1.59 | 2.28 | 0.07 | 0.83 | 2.23 | 1.68 | 2.93 | 0.34 | 1.30 | 2.16 | 1.59 | 2.86 |
| OPM % | 9.11% | 10.22% | 15.51% | 0.52% | 4.77% | 12.68% | 8.57% | 7.20% | 1.58% | 6.03% | 9.23% | 8.32% | 10.97% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.03 | 0.31 | -0.05 | 0.05 | 0.17 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.10 | 0.09 | 0.07 | 0.09 | 0.07 | 0.09 | 0.07 | 0.16 | 0.05 | 0.05 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.31 | 0.37 | 0.30 | 0.31 | 0.34 | 0.17 | 0.21 | 0.49 | 0.54 | 0.54 | 0.49 | 0.53 | 0.42 |
| Profit before tax | 1.23 | 1.13 | 1.91 | 0.70 | 0.73 | 1.92 | 1.45 | 2.45 | -0.24 | 0.71 | 1.67 | 1.06 | 2.44 |
| Tax % | 27.64% | 15.93% | 29.84% | 27.14% | 26.03% | 25.52% | 24.14% | 25.71% | 4.17% | 25.35% | 25.15% | 27.36% | 18.85% |
| Net Profit | 0.90 | 0.96 | 1.35 | 0.51 | 0.54 | 1.42 | 1.09 | 1.82 | -0.25 | 0.53 | 1.26 | 0.77 | 1.98 |
| EPS in Rs | 1.82 | 1.95 | 2.74 | 1.03 | 1.09 | 2.88 | 2.21 | 3.69 | -0.51 | 1.07 | 2.55 | 1.56 | 4.01 |
Last Updated: December 28, 2025, 2:33 pm
Below is a detailed analysis of the quarterly data for Vera Synthetic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 26.08 Cr.. The value appears strong and on an upward trend. It has increased from 19.11 Cr. (Mar 2025) to 26.08 Cr., marking an increase of 6.97 Cr..
- For Expenses, as of Sep 2025, the value is 23.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.52 Cr. (Mar 2025) to 23.22 Cr., marking an increase of 5.70 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.86 Cr.. The value appears strong and on an upward trend. It has increased from 1.59 Cr. (Mar 2025) to 2.86 Cr., marking an increase of 1.27 Cr..
- For OPM %, as of Sep 2025, the value is 10.97%. The value appears strong and on an upward trend. It has increased from 8.32% (Mar 2025) to 10.97%, marking an increase of 2.65%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.42 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.53 Cr. (Mar 2025) to 0.42 Cr., marking a decrease of 0.11 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.44 Cr.. The value appears strong and on an upward trend. It has increased from 1.06 Cr. (Mar 2025) to 2.44 Cr., marking an increase of 1.38 Cr..
- For Tax %, as of Sep 2025, the value is 18.85%. The value appears to be improving (decreasing) as expected. It has decreased from 27.36% (Mar 2025) to 18.85%, marking a decrease of 8.51%.
- For Net Profit, as of Sep 2025, the value is 1.98 Cr.. The value appears strong and on an upward trend. It has increased from 0.77 Cr. (Mar 2025) to 1.98 Cr., marking an increase of 1.21 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.01. The value appears strong and on an upward trend. It has increased from 1.56 (Mar 2025) to 4.01, marking an increase of 2.45.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:25 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.58 | 24.32 | 21.89 | 18.13 | 22.15 | 33.73 | 32.29 | 27.76 | 34.98 | 40.70 | 39.38 | 42.03 | 45.19 |
| Expenses | 18.67 | 23.37 | 21.02 | 17.17 | 19.86 | 31.03 | 29.22 | 25.43 | 31.93 | 37.77 | 35.74 | 38.60 | 40.74 |
| Operating Profit | 0.91 | 0.95 | 0.87 | 0.96 | 2.29 | 2.70 | 3.07 | 2.33 | 3.05 | 2.93 | 3.64 | 3.43 | 4.45 |
| OPM % | 4.65% | 3.91% | 3.97% | 5.30% | 10.34% | 8.00% | 9.51% | 8.39% | 8.72% | 7.20% | 9.24% | 8.16% | 9.85% |
| Other Income | 0.18 | 0.18 | 0.06 | 0.02 | 0.10 | 0.17 | 0.17 | 1.05 | 0.26 | 0.17 | 0.07 | 0.33 | 0.00 |
| Interest | 0.33 | 0.35 | 0.13 | 0.10 | 0.37 | 0.25 | 0.19 | 0.16 | 0.16 | 0.16 | 0.08 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.38 | 0.40 | 0.26 | 0.48 | 0.65 | 0.67 | 0.61 | 0.51 | 0.49 | 1.18 | 1.02 | 0.95 |
| Profit before tax | 0.48 | 0.40 | 0.40 | 0.62 | 1.54 | 1.97 | 2.38 | 2.61 | 2.64 | 2.45 | 2.45 | 2.74 | 3.50 |
| Tax % | 31.25% | 90.00% | 32.50% | 32.26% | 31.17% | 28.93% | 21.85% | 28.74% | 25.76% | 25.71% | 27.35% | 25.91% | |
| Net Profit | 0.33 | 0.05 | 0.27 | 0.43 | 1.06 | 1.40 | 1.85 | 1.86 | 1.97 | 1.82 | 1.80 | 2.03 | 2.75 |
| EPS in Rs | 1.83 | 0.28 | 1.50 | 2.39 | 2.94 | 2.84 | 3.75 | 3.77 | 3.99 | 3.69 | 3.65 | 4.11 | 5.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -84.85% | 440.00% | 59.26% | 146.51% | 32.08% | 32.14% | 0.54% | 5.91% | -7.61% | -1.10% | 12.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 524.85% | -380.74% | 87.25% | -114.44% | 0.07% | -31.60% | 5.37% | -13.53% | 6.52% | 13.88% |
Vera Synthetic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 45% |
| 5 Years: | 2% |
| 3 Years: | 1% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | % |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.80 | 1.80 | 1.80 | 1.80 | 3.60 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 | 4.94 |
| Reserves | 1.61 | 2.40 | 2.67 | 2.33 | 1.58 | 6.70 | 8.55 | 10.41 | 12.38 | 14.20 | 15.99 | 18.02 | 20.00 |
| Borrowings | 3.31 | 1.27 | 0.81 | 0.85 | 5.01 | 1.76 | 1.40 | 1.82 | 1.68 | 1.13 | 0.00 | 0.00 | 0.03 |
| Other Liabilities | 1.79 | 1.59 | 2.04 | 2.89 | 5.12 | 2.29 | 3.37 | 3.44 | 4.52 | 2.92 | 2.52 | 3.78 | 5.65 |
| Total Liabilities | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
| Fixed Assets | 2.01 | 2.41 | 2.40 | 1.06 | 3.45 | 3.97 | 4.01 | 4.47 | 3.05 | 6.08 | 6.57 | 5.65 | 5.27 |
| CWIP | 0.37 | 0.37 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.13 | 4.28 | 4.92 | 6.81 | 11.86 | 11.72 | 14.25 | 16.14 | 20.47 | 17.11 | 16.88 | 21.09 | 25.35 |
| Total Assets | 8.51 | 7.06 | 7.32 | 7.87 | 15.31 | 15.69 | 18.26 | 20.61 | 23.52 | 23.19 | 23.45 | 26.74 | 30.62 |
Below is a detailed analysis of the balance sheet data for Vera Synthetic Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.94 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.94 Cr..
- For Reserves, as of Sep 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.02 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.98 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.78 Cr. (Mar 2025) to 5.65 Cr., marking an increase of 1.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 30.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
- For Fixed Assets, as of Sep 2025, the value is 5.27 Cr.. The value appears to be declining and may need further review. It has decreased from 5.65 Cr. (Mar 2025) to 5.27 Cr., marking a decrease of 0.38 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 25.35 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2025) to 25.35 Cr., marking an increase of 4.26 Cr..
- For Total Assets, as of Sep 2025, the value is 30.62 Cr.. The value appears strong and on an upward trend. It has increased from 26.74 Cr. (Mar 2025) to 30.62 Cr., marking an increase of 3.88 Cr..
Notably, the Reserves (20.00 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -2.40 | -0.32 | 0.06 | 0.11 | -2.72 | 0.94 | 1.67 | 0.51 | 1.37 | 1.80 | 3.64 | 3.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54.81 | 46.83 | 45.69 | 36.04 | 136.28 | 82.67 | 92.01 | 83.36 | 89.01 | 82.15 | 27.06 | 37.95 |
| Inventory Days | 50.65 | 13.18 | 21.15 | 31.97 | 38.30 | 5.46 | 28.52 | 51.60 | 30.23 | 38.86 | 68.81 | 84.39 |
| Days Payable | 11.54 | 10.23 | 16.10 | 7.05 | 81.62 | 16.38 | 23.50 | 33.41 | 37.57 | 14.65 | 7.57 | 26.02 |
| Cash Conversion Cycle | 93.91 | 49.77 | 50.74 | 60.97 | 92.96 | 71.76 | 97.02 | 101.55 | 81.67 | 106.36 | 88.30 | 96.32 |
| Working Capital Days | 36.54 | 20.86 | 23.18 | 5.44 | 45.98 | 70.01 | 86.02 | 117.68 | 134.61 | 101.88 | 80.17 | 143.99 |
| ROCE % | 12.31% | 9.86% | 14.04% | 25.18% | 18.82% | 17.96% | 16.47% | 15.48% | 13.29% | 12.28% | 12.26% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Diluted EPS (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| Cash EPS (Rs.) | 6.18 | 6.02 | 4.67 | 5.01 | 4.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 46.51 | 42.41 | 38.77 | 35.08 | 31.09 |
| Revenue From Operations / Share (Rs.) | 85.44 | 79.80 | 82.48 | 70.89 | 56.95 |
| PBDIT / Share (Rs.) | 7.62 | 7.53 | 6.28 | 6.71 | 6.85 |
| PBIT / Share (Rs.) | 5.54 | 5.15 | 5.30 | 5.68 | 5.62 |
| PBT / Share (Rs.) | 5.54 | 4.98 | 4.97 | 5.36 | 5.29 |
| Net Profit / Share (Rs.) | 4.11 | 3.64 | 3.69 | 3.99 | 3.76 |
| PBDIT Margin (%) | 8.91 | 9.43 | 7.61 | 9.46 | 12.03 |
| PBIT Margin (%) | 6.48 | 6.44 | 6.42 | 8.01 | 9.86 |
| PBT Margin (%) | 6.48 | 6.24 | 6.02 | 7.56 | 9.28 |
| Net Profit Margin (%) | 4.80 | 4.56 | 4.46 | 5.62 | 6.60 |
| Return on Networth / Equity (%) | 8.83 | 8.58 | 9.51 | 11.36 | 12.09 |
| Return on Capital Employeed (%) | 11.91 | 12.13 | 13.28 | 15.23 | 16.66 |
| Return On Assets (%) | 7.57 | 7.65 | 7.84 | 8.36 | 9.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.06 | 0.08 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.09 | 0.08 |
| Asset Turnover Ratio (%) | 1.68 | 1.69 | 1.74 | 1.59 | 1.45 |
| Current Ratio (X) | 5.44 | 6.58 | 4.80 | 3.95 | 4.00 |
| Quick Ratio (X) | 3.72 | 4.56 | 3.91 | 3.55 | 3.38 |
| Inventory Turnover Ratio (X) | 7.26 | 4.29 | 7.26 | 5.38 | 4.94 |
| Interest Coverage Ratio (X) | 6735.87 | 44.96 | 19.25 | 21.30 | 20.70 |
| Interest Coverage Ratio (Post Tax) (X) | 3633.35 | 22.73 | 12.29 | 13.66 | 12.35 |
| Enterprise Value (Cr.) | 32.30 | 20.24 | 35.29 | 12.33 | 14.28 |
| EV / Net Operating Revenue (X) | 0.76 | 0.51 | 0.86 | 0.35 | 0.50 |
| EV / EBITDA (X) | 8.59 | 5.45 | 11.38 | 3.73 | 4.22 |
| MarketCap / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| Price / BV (X) | 1.42 | 1.23 | 1.89 | 0.74 | 1.04 |
| Price / Net Operating Revenue (X) | 0.77 | 0.65 | 0.88 | 0.36 | 0.56 |
| EarningsYield | 0.06 | 0.06 | 0.05 | 0.15 | 0.11 |
After reviewing the key financial ratios for Vera Synthetic Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 5. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 6.02 (Mar 24) to 6.18, marking an increase of 0.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.51. It has increased from 42.41 (Mar 24) to 46.51, marking an increase of 4.10.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 85.44. It has increased from 79.80 (Mar 24) to 85.44, marking an increase of 5.64.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.62. This value is within the healthy range. It has increased from 7.53 (Mar 24) to 7.62, marking an increase of 0.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 5.15 (Mar 24) to 5.54, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.54, marking an increase of 0.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 4.11. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 4.11, marking an increase of 0.47.
- For PBDIT Margin (%), as of Mar 25, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 9.43 (Mar 24) to 8.91, marking a decrease of 0.52.
- For PBIT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 6.48, marking an increase of 0.04.
- For PBT Margin (%), as of Mar 25, the value is 6.48. This value is below the healthy minimum of 10. It has increased from 6.24 (Mar 24) to 6.48, marking an increase of 0.24.
- For Net Profit Margin (%), as of Mar 25, the value is 4.80. This value is below the healthy minimum of 5. It has increased from 4.56 (Mar 24) to 4.80, marking an increase of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.83. This value is below the healthy minimum of 15. It has increased from 8.58 (Mar 24) to 8.83, marking an increase of 0.25.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.91. This value is within the healthy range. It has decreased from 12.13 (Mar 24) to 11.91, marking a decrease of 0.22.
- For Return On Assets (%), as of Mar 25, the value is 7.57. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 7.57, marking a decrease of 0.08.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.68. It has decreased from 1.69 (Mar 24) to 1.68, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.44. This value exceeds the healthy maximum of 3. It has decreased from 6.58 (Mar 24) to 5.44, marking a decrease of 1.14.
- For Quick Ratio (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 2. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.26. This value is within the healthy range. It has increased from 4.29 (Mar 24) to 7.26, marking an increase of 2.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6,735.87. This value is within the healthy range. It has increased from 44.96 (Mar 24) to 6,735.87, marking an increase of 6,690.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3,633.35. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 3,633.35, marking an increase of 3,610.62.
- For Enterprise Value (Cr.), as of Mar 25, the value is 32.30. It has increased from 20.24 (Mar 24) to 32.30, marking an increase of 12.06.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 24) to 0.76, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 8.59. This value is within the healthy range. It has increased from 5.45 (Mar 24) to 8.59, marking an increase of 3.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.42, marking an increase of 0.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.77, marking an increase of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vera Synthetic Ltd:
- Net Profit Margin: 4.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.91% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.83% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3633.35
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.6 (Industry average Stock P/E: 325.03)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Synthetic/Silk | Office No.UL-27, Pattani Plaza, Bhavnagar Gujarat 364002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sunil D Makwana | Chairman & Managing Director |
| Mrs. Meera S Makwana | Whole Time Director |
| Mr. Devjibhai P Makwana | Executive Director |
| Mr. Dineshbhai M Patel | Independent Director |
| Mrs. Bansari Parin Shah | Independent Director |
| Mr. Ravikumar B Adhiya | Independent Director |
FAQ
What is the intrinsic value of Vera Synthetic Ltd?
Vera Synthetic Ltd's intrinsic value (as of 15 January 2026) is ₹47.09 which is 32.63% lower the current market price of ₹69.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹34.5 Cr. market cap, FY2025-2026 high/low of ₹82.5/66.0, reserves of ₹20.00 Cr, and liabilities of ₹30.62 Cr.
What is the Market Cap of Vera Synthetic Ltd?
The Market Cap of Vera Synthetic Ltd is 34.5 Cr..
What is the current Stock Price of Vera Synthetic Ltd as on 15 January 2026?
The current stock price of Vera Synthetic Ltd as on 15 January 2026 is ₹69.9.
What is the High / Low of Vera Synthetic Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vera Synthetic Ltd stocks is ₹82.5/66.0.
What is the Stock P/E of Vera Synthetic Ltd?
The Stock P/E of Vera Synthetic Ltd is 12.6.
What is the Book Value of Vera Synthetic Ltd?
The Book Value of Vera Synthetic Ltd is 50.5.
What is the Dividend Yield of Vera Synthetic Ltd?
The Dividend Yield of Vera Synthetic Ltd is 0.00 %.
What is the ROCE of Vera Synthetic Ltd?
The ROCE of Vera Synthetic Ltd is 12.3 %.
What is the ROE of Vera Synthetic Ltd?
The ROE of Vera Synthetic Ltd is 9.07 %.
What is the Face Value of Vera Synthetic Ltd?
The Face Value of Vera Synthetic Ltd is 10.0.